Last reviewed · How we verify
NCT06549764: YAM
The YAM-project (Youth Aware of Mental Health)
NA trial testing Youth Aware of Mental Health in Prevention, Suicide in 297 participants. Completed in 25 July 2025.
18 February 2025
Quick facts
| Lead sponsor | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 297 |
| Start date | 8 August 2024 |
| Primary completion | 18 February 2025 |
| Estimated completion | 25 July 2025 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Youth Aware of Mental Health
Conditions studied
- Prevention, Suicide — all drugs for Prevention, Suicide →
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Who can join
Adults 15 to 17, any sex, with Prevention, Suicide. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Two-armed, cluster, randimized feasibility trial investigating the feasibility of the Youth Aware of Mental Health (YAM) intervention provided 9th grade students.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Youth Aware of Mental Health for Danish School Adolescents: Study Protocol for a Cluster-Randomized Feasibility Pilot Trial.
Harris LK, Heinrichsen M, Petri M, Elberling H, et al · · 2026 · PMID 41800799 · DOI 10.1002/mpr.70064
Verify or expand the search:
- PubMed search for NCT06549764
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prevention, Suicide
Currently open trials in the same condition.
- NCT06785311 — Native Spirit: Significant Aim 3: Intervention · NA · recruiting
Other Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital trials
Trials by the same sponsor.
- NCT07404085 — Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations · NA · recruiting
- NCT07302165 — PreParent: Internet-based Digital Tools to Screen for and Prevent Postpartum Depression in Parents-to-be · NA · enrolling by invitation
- NCT06919133 — The Effect of Digital Markers in the Self-management of Depressive Symptoms · NA · enrolling by invitation
- NCT06755710 — Patient Engagement in PTSD Treatment (PEP) · NA · recruiting
- NCT06993831 — ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in Schizophrenia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06549764 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
- Last refreshed: 29 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06549764.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing